Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MALDI-TOF Mass Spectrometry01:19

MALDI-TOF Mass Spectrometry

4.8K
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
4.8K
Mass Spectrometry: Complex Analysis01:21

Mass Spectrometry: Complex Analysis

782
Mass spectrometry is an important technique for the identification of pure compounds. However, it has some limitations for the analysis of complex mixtures, often due to excessive fragmentation making the spectrum too complicated to decipher. Mass spectrometry can be combined with suitable separation methods in sequence, forming hyphenated methods, which are useful in the analysis of complex mixtures.
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
782
Tandem Mass Spectrometry01:21

Tandem Mass Spectrometry

1.0K
Tandem mass spectrometry is a technique that uses multiple mass analyzers in series to obtain a higher selectivity and signal-to-noise ratio for the analyte. Instruments with multiple analyzers separated by an interaction cell enable secondary fragmentation and selected study of the fragment ions.
Secondary fragmentations occur in the interaction cell and can be induced by various factors. Fragmentation induced by collision with inert gases, such as N2, Ar, He, etc., is called collision-induced...
1.0K
Peptide Identification Using Tandem Mass Spectrometry01:33

Peptide Identification Using Tandem Mass Spectrometry

6.4K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
6.4K
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview01:19

Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview

741
In inductively coupled plasma–mass spectrometry (ICP–MS), an inductively coupled plasma (ICP) torch is used as an atomizer and ionizer. Solid samples are dissolved and volatilized before being introduced into the high-temperature argon plasma, while solution samples are nebulized and passed through the high-temperature argon plasma. Plasma dissociates the analytes and ionizes their component atoms to form a mixture of positive ions and molecular species. The positive ions are then...
741
Mass Spectrometers01:16

Mass Spectrometers

5.5K
This lesson details the instrumentation of a mass spectrometer—a physical instrument to perform mass spectrometry on analyte molecules and record the characteristic mass spectra. This is achieved via three chief functions:
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reference Interval Establishment for Four Coagulation Parameters Using Indirect Methods in a High-Altitude Chinese Population: A Retrospective Real-World Analysis.

Journal of clinical laboratory analysis·2026
Same author

Advances in laboratory diagnostic studies of pheochromocytoma and paraganglioma.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Liquid chromatography-tandem mass spectrometry-based urinary steroid profiling applied to primary aldosteronism diagnosis.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same author

Calcium Dobesilate Interference in Two Urinary Total Protein Detection Methods.

Journal of clinical laboratory analysis·2026
Same author

Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Quantification of Cortisol and Dexamethasone Establishes a Platform-Specific Dexamethasone Lower Limit and Improves Diagnostic Specificity of the 1-mg Overnight Dexamethasone Suppression Test.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Same author

Beyond cortisol: multiplex steroid profiling after overnight dexamethasone suppression to optimize Cushing's syndrome screening.

Endocrine·2025

Related Experiment Video

Updated: Jul 4, 2025

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
07:34

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

12.8K

Evolution of LC-MS/MS in clinical laboratories.

Songlin Yu1, Yutong Zou1, Xiaoli Ma1

  • 1Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|January 27, 2024
PubMed
Summary

Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers clinical advantages but faces challenges in biomarker selection, automation, and standardization. Addressing these issues through utility-driven approaches and collaborative efforts will enhance its clinical integration.

Keywords:
Analyte selectionAutomationClinical laboratoryLiquid chromatography–tandem mass spectrometryQuality controlReference interval

More Related Videos

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
11:00

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS

Published on: May 20, 2013

22.5K
LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.2K

Related Experiment Videos

Last Updated: Jul 4, 2025

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
07:34

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

12.8K
Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
11:00

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS

Published on: May 20, 2013

22.5K
LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism
06:04

LC-MS Analysis of Human Platelets as a Platform for Studying Mitochondrial Metabolism

Published on: April 4, 2016

11.2K

Area of Science:

  • Clinical Chemistry
  • Analytical Chemistry
  • Biomarker Discovery

Background:

  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is increasingly recognized for its clinical utility.
  • Widespread adoption is currently limited by challenges in analyte selection, automation, and standardization.

Purpose of the Study:

  • To review the current challenges hindering the clinical application of LC-MS/MS.
  • To propose potential resolutions for overcoming these limitations and facilitating broader adoption.

Main Methods:

  • Comprehensive literature review of LC-MS/MS applications and challenges in clinical practice.
  • Analysis of current limitations including analyte selection, automation, reference intervals, and quality control.
  • Discussion of proposed solutions focusing on utility-driven biomarker selection, methodological innovation, standardization, and quality assurance.

Main Results:

  • Key challenges identified include inappropriate biomarker selection, insufficient automation, lack of standardized reference intervals, and inadequate quality control programs.
  • Proposed resolutions emphasize prioritizing practical utility in biomarker selection, developing high-throughput automation, establishing multi-center reference intervals, and creating commercial quality control materials.
  • Harmonization and standardization efforts are crucial for clinical LC-MS/MS, with commercial kits and LDTs expected to coexist.

Conclusions:

  • Addressing challenges in analyte selection, automation, and standardization is vital for the clinical integration of LC-MS/MS.
  • Future advancements will focus on simplification, automation, intelligence, and standardization, enhancing its routine use for clinicians and technicians.
  • Collaborative efforts among professionals are essential for the successful clinical implementation of LC-MS/MS.